Wooi F. Lim

South Parks Road
Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Tissue-specific modulation of CRISPR activity by miRNA-sensing guide RNAs.

Tissue-specific modulation of CRISPR activity by miRNA-sensing guide RNAs.

Journal: Nucleic acids research
Published: July 30, 2024

RNA Transcript Diversity in Neuromuscular Research.

RNA Transcript Diversity in Neuromuscular Research.

Journal: Journal of neuromuscular diseases
Published: May 14, 2023

PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice.

PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice.

Journal: EMBO molecular medicine
Published: March 07, 2023

Investigating Eukaryotic Elongation Factor 2 Kinase/Eukaryotic Translation Elongation Factor 2 Pathway Regulation and Its Role in Protein Synthesis Impairment during Disuse-Induced Skeletal Muscle Atrophy.

Investigating Eukaryotic Elongation Factor 2 Kinase/Eukaryotic Translation Elongation Factor 2 Pathway Regulation and Its Role in Protein Synthesis Impairment during Disuse-Induced Skeletal Muscle Atrophy.

Journal: The American journal of pathology
Published: September 23, 2022

LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice.

LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice.

Journal: Nature communications
Published: February 16, 2022

An LNA-amide modification that enhances the cell uptake and activity of phosphorothioate exon-skipping oligonucleotides.

An LNA-amide modification that enhances the cell uptake and activity of phosphorothioate exon-skipping oligonucleotides.

Journal: Nature communications
Published: February 02, 2022

Author Correction: GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.

Author Correction: GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.

Journal: Nature communications
Published: December 17, 2021

AR cooperates with SMAD4 to maintain skeletal muscle homeostasis.

AR cooperates with SMAD4 to maintain skeletal muscle homeostasis.

Journal: Acta neuropathologica
Published: November 15, 2021

Variants in ATP6V0A1 cause progressive myoclonus epilepsy and developmental and epileptic encephalopathy.

Variants in ATP6V0A1 cause progressive myoclonus epilepsy and developmental and epileptic encephalopathy.

Journal: Brain communications
Published: July 02, 2021

Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity.

Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity.

Journal: Science advances
Published: March 25, 2021

Dystrophin involvement in peripheral circadian SRF signalling.

Dystrophin involvement in peripheral circadian SRF signalling.

Journal: Life science alliance
Published: January 07, 2021

GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.

GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.

Journal: Nature communications
Published: March 09, 2020
Showing 1-12 of 12

Last Updated: 09/26/2026